EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
Canada - TSX:EXE - CA30224T8639 - Common Stock
19.76 CAD
+0.12 (+0.61%)
Taking everything into account, EXE scores 6 out of 10 in our fundamental rating. EXE was compared to 14 industry peers in the Health Care Providers & Services industry. EXE scores excellent on profitability, but there are some minor concerns on its financial health. EXE has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
EXE had positive earnings in the past year.
In the past year EXE had a positive cash flow from operations.
EXE had positive earnings in each of the past 5 years.
In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.69%, EXE belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
Looking at the Return On Equity, with a value of 55.86%, EXE belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 19.22%, EXE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EXE is above the industry average of 7.17%.
The last Return On Invested Capital (19.22%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.69% | ||
| ROE | 55.86% | ||
| ROIC | 19.22% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
EXE has a better Profit Margin (5.51%) than 85.71% of its industry peers.
EXE's Profit Margin has improved in the last couple of years.
EXE's Operating Margin of 7.78% is fine compared to the rest of the industry. EXE outperforms 78.57% of its industry peers.
EXE's Operating Margin has improved in the last couple of years.
EXE has a worse Gross Margin (13.86%) than 85.71% of its industry peers.
In the last couple of years the Gross Margin of EXE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.78% | ||
| PM (TTM) | 5.51% | ||
| GM | 13.86% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXE is creating value.
EXE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EXE has been reduced compared to 5 years ago.
EXE has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.35 indicates that EXE is not in any danger for bankruptcy at the moment.
EXE has a better Altman-Z score (3.35) than 85.71% of its industry peers.
EXE has a debt to FCF ratio of 3.60. This is a good value and a sign of high solvency as EXE would need 3.60 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.60, EXE is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
A Debt/Equity ratio of 1.79 is on the high side and indicates that EXE has dependencies on debt financing.
EXE has a worse Debt to Equity ratio (1.79) than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 3.6 | ||
| Altman-Z | 3.35 |
ROIC/WACC2.44
WACC7.89%
2.3 Liquidity
EXE has a Current Ratio of 0.85. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a better Current ratio (0.85) than 64.29% of its industry peers.
A Quick Ratio of 0.85 indicates that EXE may have some problems paying its short term obligations.
The Quick ratio of EXE (0.85) is better than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 46.37% over the past year.
Measured over the past years, EXE shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.74% on average per year.
EXE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.68%.
The Revenue has been growing slightly by 5.31% on average over the past years.
EPS 1Y (TTM)46.37%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%37.31%
Revenue 1Y (TTM)8.68%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%10.03%
3.2 Future
EXE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.23% yearly.
Based on estimates for the next years, EXE will show a small growth in Revenue. The Revenue will grow by 5.69% on average per year.
EPS Next Y23.8%
EPS Next 2Y10.47%
EPS Next 3Y5.59%
EPS Next 5Y8.23%
Revenue Next Year12.04%
Revenue Next 2Y9.4%
Revenue Next 3Y6.78%
Revenue Next 5Y5.69%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 21.25, which indicates a rather expensive current valuation of EXE.
EXE's Price/Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 85.71% of the companies in the same industry.
EXE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.56, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 20.29, the valuation of EXE can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 85.71% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of EXE to the average of the S&P500 Index (34.62), we can say EXE is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.25 | ||
| Fwd PE | 20.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EXE is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, EXE is valued a bit cheaper than 64.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.98 | ||
| EV/EBITDA | 12.35 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.89
PEG (5Y)0.93
EPS Next 2Y10.47%
EPS Next 3Y5.59%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 2.63%. Purely for dividend investing, there may be better candidates out there.
EXE's Dividend Yield is rather good when compared to the industry average which is at 3.46. EXE pays more dividend than 85.71% of the companies in the same industry.
EXE's Dividend Yield is comparable with the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.63% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
48.82% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.82%
EPS Next 2Y10.47%
EPS Next 3Y5.59%
TSX:EXE (11/17/2025, 7:00:00 PM)
19.76
+0.12 (+0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners27.27%
Inst Owner ChangeN/A
Ins Owners13.13%
Ins Owner ChangeN/A
Market Cap1.66B
Revenue(TTM)1.51B
Net Income(TTM)83.18M
Analysts75
Price Target17.02 (-13.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.63% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP48.82%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.06%
PT rev (3m)4.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.96%
EPS NY rev (3m)29.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.87%
Revenue NY rev (3m)0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.25 | ||
| Fwd PE | 20.29 | ||
| P/S | 1.1 | ||
| P/FCF | 20.98 | ||
| P/OCF | 12.6 | ||
| P/B | 11.12 | ||
| P/tB | 50.22 | ||
| EV/EBITDA | 12.35 |
EPS(TTM)0.93
EY4.71%
EPS(NY)0.97
Fwd EY4.93%
FCF(TTM)0.94
FCFY4.77%
OCF(TTM)1.57
OCFY7.93%
SpS18
BVpS1.78
TBVpS0.39
PEG (NY)0.89
PEG (5Y)0.93
Graham Number6.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.69% | ||
| ROE | 55.86% | ||
| ROCE | 25.43% | ||
| ROIC | 19.22% | ||
| ROICexc | 22.81% | ||
| ROICexgc | 32.51% | ||
| OM | 7.78% | ||
| PM (TTM) | 5.51% | ||
| GM | 13.86% | ||
| FCFM | 5.23% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 3.6 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 154.92% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 10.8 | ||
| Cash Conversion | 86.92% | ||
| Profit Quality | 94.89% | ||
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 3.35 |
F-Score6
WACC7.89%
ROIC/WACC2.44
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.37%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%37.31%
EPS Next Y23.8%
EPS Next 2Y10.47%
EPS Next 3Y5.59%
EPS Next 5Y8.23%
Revenue 1Y (TTM)8.68%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%10.03%
Revenue Next Year12.04%
Revenue Next 2Y9.4%
Revenue Next 3Y6.78%
Revenue Next 5Y5.69%
EBIT growth 1Y39.21%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year-0.49%
EBIT Next 3Y2.81%
EBIT Next 5Y2.76%
FCF growth 1Y179.71%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y406.79%
OCF growth 3Y31.32%
OCF growth 5Y26.02%
EXTENDICARE INC / EXE.CA FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
Can you provide the valuation status for EXTENDICARE INC?
ChartMill assigns a valuation rating of 6 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.
What is the profitability of EXE stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for EXE stock?
The Price/Earnings (PE) ratio for EXTENDICARE INC (EXE.CA) is 21.25 and the Price/Book (PB) ratio is 11.12.
What is the financial health of EXTENDICARE INC (EXE.CA) stock?
The financial health rating of EXTENDICARE INC (EXE.CA) is 5 / 10.